Support Line: 0800 002 9002
General Enquiries: 01223 870008
Donate

News Archive

Avelumab

RCC combo approved on CDF

RCC combo approved on CDF

Avelumab| Axitinib
The UK's first as breakthrough kidney cancer combination treatment has been approved for immediate use through the ...
Preliminary results for avelumab + axitinib..

Preliminary results for avelumab + axitinib..

Avelumab| Axitinib
.... as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an ...